Breaking Down Nevro: 10 Analysts Share Their Views

Ratings for Nevro (NYSE:NVRO) were provided by 10 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and…

Unveiling 7 Analyst Insights On EPR Props

Across the recent three months, 7 analysts have shared their insights on EPR Props (NYSE:EPR), expressing a variety of opinions spanning from bullish to bearish. The table below provides a snapshot of their recent ratings, showcasing how sentiments hav…

Unveiling 3 Analyst Insights On Arcturus Therapeutics

Providing a diverse range of perspectives from bullish to bearish, 3 analysts have published ratings on Arcturus Therapeutics (NASDAQ:ARCT) in the last three months. The table below summarizes their recent ratings, showcasing the evolving sentiments wi…

8 Analysts Assess Equinix: What You Need To Know

Equinix (NASDAQ:EQIX) underwent analysis by 8 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30…